| イタリア | トルコ | オーストリア | |
| 胆嚢摘出術 | から $7,000 | から $2,900 | から $9,000 |
| 幹細胞療法 | から $10,000 | から $7,200 | から $8,500 |
| ホルモン療法 | から $2,500 | から $399 | から $7,000 |
| 選択的アフェレーシス | から $3,100 | から $1,550 | - |
Bookimedはクローン病治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。クローン病治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。クローン病治療の旅路でお一人になることはありません。
Advanced Crohn's disease treatments in Italy include IL-23 inhibitors like Risankizumab and oral JAK inhibitors such as Upadacitinib. Specialized centers offer stem cell therapy for refractory cases. Leading facilities in Milan and Rome provide biologic therapies, clinical trials, and gut-selective integrin inhibitors for targeted inflammation control.
Bookimed Expert Insight: While many search for the newest drugs, the real advantage in Italy is the integration of research hubs. Mater Olbia Hospital in Rome combines expertise from the Qatar Foundation and Fondazione Policlinico Gemelli. This partnership allows patients to access clinical trials for advanced combination treatments (ACT). These protocols use multiple biologics simultaneously for cases that do not respond to standard care.
Patient Consensus: Patients note that seeking private consultations can significantly shorten wait times for high-demand biologics like Ustekinumab. Many suggest preparing detailed flare history and medical records to fast-track approvals within specialized regional networks.
Italy hosts leading centers for Crohns disease specializing in biological therapies and advanced diagnostics. Humanitas Research Hospital and Agostino Gemelli University Policlinic serve as primary referral hubs. These facilities utilize multidisciplinary teams including specialized surgeons and gastroenterologists to manage complex inflammatory bowel conditions.
Bookimed Expert Insight: Patients seeking premium care often choose La Madonnina Clinic in Milan. It is part of the San Donato Network and treats high-profile individuals. While it is a private facility, its link to major research networks ensures access to top experts. This presents a faster alternative to public university hospitals where wait times are often significant.
Patient Consensus: Patients often recommend choosing university-affiliated hospitals over general facilities for better specialty care. Many note that northern Italian hospitals typically offer more updated medical protocols than southern regions.
Italy supports Crohn's disease care through the Servizio Sanitario Nazionale (SSN). It classifies the condition as a chronic illness. This status grants patients a ticket exemption for diagnostic tests and specialist visits. The system fully subsidizes biological therapies and surgical procedures in public hospitals.
Bookimed Expert Insight: Patients can navigate regional wait times by using Italy's cross-regional referral system. If a local facility is overbooked, the SSN may authorize and fund treatment in other regions. This is especially useful for complex surgeries at high-volume centers like Mater Olbia Hospital. Utilizing this legislative right ensures timely access to specialized gastroenterology teams without incurring private surgical fees.
Patient Consensus: Patients note that registering with a regional IBD hub provides a dedicated coordinator. This significantly simplifies scheduling appointments and obtaining prescriptions compared to managing standard public referrals alone.
Specialists in Italy treat Crohn's disease using guidelines from the European Crohn's and Colitis Organisation (ECCO). They follow a step-up approach, starting with aminosalicylates or steroids. Biological therapies, such as IL-12/23 inhibitors and JAK inhibitors, are standard for moderate-to-severe cases.
Bookimed Expert Insight: Italian gastrointestinal care is dominated by large medical networks like the San Donato Group. This helps clinical teams quickly coordinate with surgeons if medication stops working. Patients often find better continuity in Milan-based clinics with large multidisciplinary GI departments.
Patient Consensus: Patients note that care is led by specialist gastroenterologists rather than GPs. Most recommend discussing biologic therapy early if conventional drugs fail to manage flare-ups.
Leading Italian centres for Crohn's disease treatment include Mater Olbia Hospital in Rome and La Madonnina Clinic in Milan. These facilities specialise in multidisciplinary care. They offer biological therapies and diagnostic techniques like capsule endoscopy. Experts focus on managing chronic intestinal inflammation using research-based protocols.
Bookimed Expert Insight: Italian healthcare excellence often stems from IRCCS status. This designates a facility as a Scientific Institute for Research and Healthcare. Mater Olbia Hospital integrates the research-heavy model used by Agostino Gemelli. Patients benefit from 22 specialised departments and 113 doctors who apply academic findings to clinical practice.
Patient Consensus: Patients find that coordinating with a local GP in Italy helps secure hospital referrals. It is important to confirm clinical trial suitability with home teams before seeking biological care.
Australian medical tourists can access private Crohn’s disease treatment in Italy by paying directly for specialist services. A reciprocal agreement exists but only covers public emergency care. Private facilities provide elective diagnostics like capsule endoscopy and colonoscopies without long public wait times.
Bookimed Expert Insight: Italian private healthcare revolves around large medical groups like the San Donato Network. Choosing a clinic like La Madonnina ensures access to shared specialist resources. This network structure often provides more consistent billing and administrative support for international patients.
Patient Consensus: Patients note it is essential to bring complete pathology and biologic medication histories. Confirming infusion schedules and English-speaking support in advance helps manage potential flares while in Italy.